These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18830925)

  • 1. siRNA delivery by magnetofection.
    Mykhaylyk O; Zelphati O; Rosenecker J; Plank C
    Curr Opin Mol Ther; 2008 Oct; 10(5):493-505. PubMed ID: 18830925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomal magnetofection.
    Mykhaylyk O; Sánchez-Antequera Y; Vlaskou D; Hammerschmid E; Anton M; Zelphati O; Plank C
    Methods Mol Biol; 2010; 605():487-525. PubMed ID: 20072903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in magnetofection and its potential to deliver siRNAs in vitro.
    Mykhaylyk O; Zelphati O; Hammerschmid E; Anton M; Rosenecker J; Plank C
    Methods Mol Biol; 2009; 487():111-46. PubMed ID: 19301645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic nanoparticle and magnetic field assisted siRNA delivery in vitro.
    Mykhaylyk O; Sanchez-Antequera Y; Vlaskou D; Cerda MB; Bokharaei M; Hammerschmid E; Anton M; Plank C
    Methods Mol Biol; 2015; 1218():53-106. PubMed ID: 25319646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convenient targeting of stealth siRNA-lipoplexes to cells with chelator lipid-anchored molecules.
    Herringson TP; Altin JG
    J Control Release; 2009 Nov; 139(3):229-38. PubMed ID: 19595724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene delivery to respiratory epithelial cells by magnetofection.
    Gersting SW; Schillinger U; Lausier J; Nicklaus P; Rudolph C; Plank C; Reinhardt D; Rosenecker J
    J Gene Med; 2004 Aug; 6(8):913-22. PubMed ID: 15293350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of magnetic lipoplexes studied by single particle tracking in living cells.
    Sauer AM; de Bruin KG; Ruthardt N; Mykhaylyk O; Plank C; Bräuchle C
    J Control Release; 2009 Jul; 137(2):136-45. PubMed ID: 19358868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced transfection rates of small-interfering RNA using dioleylglutamide-based magnetic lipoplexes.
    Lee S; Shim G; Kim S; Kim YB; Kim CW; Byun Y; Oh YK
    Nucleic Acid Ther; 2011 Jun; 21(3):165-72. PubMed ID: 21749293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.
    Beh CW; Seow WY; Wang Y; Zhang Y; Ong ZY; Ee PL; Yang YY
    Biomacromolecules; 2009 Jan; 10(1):41-8. PubMed ID: 19072631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular small interfering RNA delivery using genetically engineered double-stranded RNA binding protein domain.
    Kim J; Lee SH; Choe J; Park TG
    J Gene Med; 2009 Sep; 11(9):804-12. PubMed ID: 19569061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronic acid complexed to biodegradable poly L-arginine for targeted delivery of siRNAs.
    Kim EJ; Shim G; Kim K; Kwon IC; Oh YK; Shim CK
    J Gene Med; 2009 Sep; 11(9):791-803. PubMed ID: 19569085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficiency of CD40 down regulation by siRNA and antisense ODN: comparison of lipofectamine and FuGENE6.
    Ebadi P; Karimi MH; Pourfathollah AA; Saheb Ghadam Lotfi A; Soheili ZS; Samiee S; Hajati S; Nadali F; Geramizadeh B; Moazzeni SM
    Iran J Immunol; 2009 Mar; 6(1):1-11. PubMed ID: 19293472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The magnetofection method: using magnetic force to enhance gene delivery.
    Plank C; Schillinger U; Scherer F; Bergemann C; Rémy JS; Krötz F; Anton M; Lausier J; Rosenecker J
    Biol Chem; 2003 May; 384(5):737-47. PubMed ID: 12817470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel cationic cholesterol derivative-based liposomes for serum-enhanced delivery of siRNA.
    Han SE; Kang H; Shim GY; Suh MS; Kim SJ; Kim JS; Oh YK
    Int J Pharm; 2008 Apr; 353(1-2):260-9. PubMed ID: 18178348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of magnetic nonviral gene transfer agents and magnetofection in vitro.
    Mykhaylyk O; Antequera YS; Vlaskou D; Plank C
    Nat Protoc; 2007; 2(10):2391-411. PubMed ID: 17947981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory formulated magnetic nanoparticles for enhancement of viral gene expression in suspension cell line.
    Bhattarai SR; Kim SY; Jang KY; Lee KC; Yi HK; Lee DY; Kim HY; Hwang PH
    J Virol Methods; 2008 Feb; 147(2):213-8. PubMed ID: 17935796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery.
    Wang XL; Xu R; Lu ZR
    J Control Release; 2009 Mar; 134(3):207-13. PubMed ID: 19135104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro and in vivo Magnetofection : a move towards gene therapy].
    Sapet C; Laurent N; Le Gourrierec L; Augier S; Zelphati O
    Ann Biol Clin (Paris); 2010; 68(2):133-42. PubMed ID: 20348045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the development of siRNA-based therapeutics for cancer.
    Shen Y
    IDrugs; 2008 Aug; 11(8):572-8. PubMed ID: 18683092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel approach for nucleic acid delivery into cancer cells.
    Vainauska D; Kozireva S; Karpovs A; Čistjakovs M; Bariševs M
    Medicina (Kaunas); 2012; 48(6):324-9. PubMed ID: 22885367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.